Mariner’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,068
Closed -$471K 848
2018
Q3
$471K Sell
4,068
-3,879
-49% -$438K 0.01% 570
2018
Q2
$1M Buy
7,947
+2,383
+43% +$290K 0.03% 401
2018
Q1
$602K Sell
5,564
-595
-10% -$65.8K 0.02% 403
2017
Q4
$675K Sell
6,159
-187
-3% -$18.7K 0.03% 345
2017
Q3
$626K Buy
6,346
+2
+0% +$194 0.03% 308
2017
Q2
$642K Sell
6,344
-8
-0.1% -$863 0.03% 301
2017
Q1
$734K Buy
6,352
+246
+4% +$28.6K 0.03% 316
2016
Q4
$733K Sell
6,106
-1,900
-24% -$210K 0.03% 309
2016
Q3
$899K Buy
8,006
+840
+12% +$96.8K 0.04% 280
2016
Q2
$887K Buy
7,166
+232
+3% +$28K 0.05% 261
2016
Q1
$779K Sell
6,934
-180
-3% -$18.7K 0.05% 264
2015
Q4
$774K Sell
7,114
-525
-7% -$60.1K 0.05% 236
2015
Q3
$762K Sell
7,639
-5,578
-42% -$607K 0.03% 286
2015
Q2
$1.51M Buy
13,217
+56
+0.4% +$6.79K 0.07% 207
2015
Q1
$1.38M Buy
13,161
+115
+0.9% +$12.3K 0.12% 152
2014
Q4
$1.57M Buy
+13,046
New +$1.71M 0.14% 124

Other funds holding CLB

Mariner's CLB Position: Q4 2018 in Review

Mariner sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 4,068 shares — an estimated $471K sold.

Mariner first reported a position in CLB in Q4 2014 and held it in 16 quarters. The position peaked at $1.57M in Q4 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Mariner reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Mariner sold 4,068 Core Laboratories shares in Q4 2018, an estimated $471K.
  • Mariner first reported a position in Core Laboratories in Q4 2014 and held it in 16 quarters.
  • Mariner's Core Laboratories position peaked at $1.57M in Q4 2014.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Mariner's 13F filing for Q4 2018, filed 13 Feb 2019.